ARCHIVES

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

AACI Backs Year 200 Goals, Secures Pledge From NCI that New Centers Won’t Be Added At Expense of Old

July 20, 1984